Literature DB >> 2156856

Transport of divalent cations with tetracycline as mediated by the transposon Tn10-encoded tetracycline resistance protein.

A Yamaguchi1, T Udagawa, T Sawai.   

Abstract

Tetracycline uptake into inverted membrane vesicles from Tn10-bearing Escherichia coli cells required divalent cations. The degree of the stimulation of tetracycline uptake by various divalent cations showed the following decreasing order: Co2+ greater than Mn2+ greater than Mg2+ greater than Cd2+ greater than Ca2+. This order is consistent with the increasing order of the dissociation constants for metal chelate complexes of tetracycline. The Hill constants for the tetracycline uptake rate with various divalent cation concentrations were one. These observations strongly suggested that a 1:1 complex of tetracycline and a divalent cation was transported by a tetracycline resistance protein. This notion was confirmed by our observations that 60Co2+ was actively taken up with tetracycline by the membrane vesicles prepared from resistant cells. In the absence of tetracycline, no uptake of 60Co2+ was observed. It is clear that the 60Co2+ uptake was mediated by the tetracycline resistance protein, because the membrane vesicles from tetracycline-sensitive cells did not show the uptake of 60Co2+ and tetracycline. The 60Co2+ uptake was inhibited in the presence of other divalent cations, without any significant effect on tetracycline uptake, indicating that these cations are also transported with tetracycline by the tetracycline resistance protein.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2156856

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

1.  Twelve-transmembrane-segment (TMS) version (DeltaTMS VII-VIII) of the 14-TMS Tet(L) antibiotic resistance protein retains monovalent cation transport modes but lacks tetracycline efflux capacity.

Authors:  J Jin; A A Guffanti; C Beck; T A Krulwich
Journal:  J Bacteriol       Date:  2001-04       Impact factor: 3.490

2.  Decreased function of the class B tetracycline efflux protein Tet with mutations at aspartate 15, a putative intramembrane residue.

Authors:  L M McMurry; M Stephan; S B Levy
Journal:  J Bacteriol       Date:  1992-10       Impact factor: 3.490

Review 3.  Active efflux mechanisms for antimicrobial resistance.

Authors:  S B Levy
Journal:  Antimicrob Agents Chemother       Date:  1992-04       Impact factor: 5.191

4.  Cloning, sequencing and analysis of the pucC genes from Rubrivivax gelatinosus strain 151 and Rhodopseudomonas acidophila strain 10050.

Authors:  A E Simmons; S J Barrett; C N Hunter; R J Cogdell
Journal:  Photosynth Res       Date:  2000       Impact factor: 3.573

Review 5.  Alkaline pH homeostasis in bacteria: new insights.

Authors:  Etana Padan; Eitan Bibi; Masahiro Ito; Terry A Krulwich
Journal:  Biochim Biophys Acta       Date:  2005-09-26

Review 6.  The TetR family of transcriptional repressors.

Authors:  Juan L Ramos; Manuel Martínez-Bueno; Antonio J Molina-Henares; Wilson Terán; Kazuya Watanabe; Xiaodong Zhang; María Trinidad Gallegos; Richard Brennan; Raquel Tobes
Journal:  Microbiol Mol Biol Rev       Date:  2005-06       Impact factor: 11.056

Review 7.  Proton-dependent multidrug efflux systems.

Authors:  I T Paulsen; M H Brown; R A Skurray
Journal:  Microbiol Rev       Date:  1996-12

8.  Mutations in the tetA(B) gene that cause a change in substrate specificity of the tetracycline efflux pump.

Authors:  G G Guay; M Tuckman; D M Rothstein
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

9.  Na+/H+ antiport activity conferred by Bacillus subtilis tetA(L), a 5' truncation product of tetA(L), and related plasmid genes upon Escherichia coli.

Authors:  J Cheng; K Baldwin; A A Guffanti; T A Krulwich
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

10.  Metabolite profiling uncovers plasmid-induced cobalt limitation under methylotrophic growth conditions.

Authors:  Patrick Kiefer; Markus Buchhaupt; Philipp Christen; Björn Kaup; Jens Schrader; Julia A Vorholt
Journal:  PLoS One       Date:  2009-11-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.